Cargando…
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Conventional cancer chemotherapies often exhibit insufficient therapeutic outcomes and dose-limiting toxicity. Therefore, there is a need for novel therapeutics and formulations with higher efficacy, improved safety, and more favorable toxicological profiles. This has promoted the development of nan...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397943/ https://www.ncbi.nlm.nih.gov/pubmed/34452096 http://dx.doi.org/10.3390/pharmaceutics13081135 |